Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Revised Consolidated Statement of Operations, Balance Sheet and Cash Flows

The financial information included in the accompanying consolidated financial statements and notes thereto reflect the effects of the corrections and other adjustments described in the preceding discussion and following tables.

Revised Consolidated Statement of Operations (in thousands,
except earnings per share data)	For the Twelve Months Ended December 31, 2020
	As Reported			Adjustment			As Revised
Selling, general and administrative expenses	$	59,398		$	278		$	59,676
Gain on Sale of Investment		(1,600	)		1,600			—
Operating Income		67,601			(1,878	)		65,723
Net Loss		(2,976	)		(1,878	)		(4,854	)
Net Loss per share - basic and diluted		(0.60	)	$	(0.15	)	$	(0.75	)
Revised Consolidated Balance Sheet (in thousands)	December 31, 2020
	As Reported			Adjustments			As Revised
Accounts payable and accrued expenses	$	29,847		$	278			30,125
Additional Paid-in Capital		1,047,504			1,600			1,049,104
Accumulated Losses		(435,562	)		(1,878	)		(437,440	)
Revised Consolidated Statement of Cash Flows (in thousands)	For the Twelve Months Ended December 31, 2020
	As Reported			Adjustment			As Revised
Net cash used in investing activities	$	77,141		$	(1,600	)		75,541
Net cash used in financing activities		(110,339	)		1,600			(108,739	)
Revised Consolidated Statement of Operations (in thousands,
except earnings per share data)	For the Three Months Ended June 30, 2020
	As Reported			Adjustment			As Revised
Gain on Sale of Investment	$	(1,600	)	$	1,600			—
Operating Income		3,765			(1,600	)		2,165
Net Loss		(15,464	)		(1,600	)		(17,064	)
Net Loss per share - basic and diluted	$	(1.44	)	$	(0.13	)	$	(1.58	)

Revised Consolidated Statement of Operations (in thousands,
except earnings per share data)	For the Six Months Ended June 30, 2020
	As Reported			Adjustment			As Revised
Gain on Sale of Investment	$	(1,600	)	$	1,600		$	—
Operating Income		(1,087	)		(1,600	)		(2,687	)
Net Loss		(36,466	)		(1,600	)		(38,066	)
Net Loss per share - basic and diluted	$	(3.33	)	$	(0.14	)	$	(3.47	)
Revised Consolidated Balance Sheet (in thousands)	June 30, 2020
	As Reported			Adjustments			As Revised
Additional Paid-in Capital	$	1,045,408		$	1,600			1,047,008
Accumulated Losses		(468,162	)		(1,600	)		(469,762	)
Revised Consolidated Statement of Cash Flows (in thousands)	For the Six Months Ended June 30, 2020
	As Reported			Adjustment			As Revised
Net cash used in investing activities	$	(1,008	)	$	(1,600	)		(2,608	)
Net cash used in financing activities		(27,291	)		1,600			(25,691	)
Revised Consolidated Statement of Operations (in thousands,
except earnings per share data)	For the Nine Months Ended September 30, 2020
	As Reported			Adjustment			As Revised
Gain on Sale of Investment		(1,600	)		1,600			—
Operating Income		65,263			(1,600	)		63,663
Net Loss		10,263			(1,600	)		8,663
Earnings (loss) per share - basic	$	0.54		$	(0.13	)	$	0.41
Earnings (loss) per share - diluted	$	0.37		$	(0.05	)	$	0.32
Revised Consolidated Balance Sheet (in thousands)	September 30, 2020
	As Reported			Adjustments			As Revised
Additional Paid-in Capital	$	1,047,167		$	1,600			1,048,767
Accumulated Losses		(422,436	)		(1,600	)		(424,036	)
Revised Consolidated Statement of Cash Flows (in thousands)	For the Nine Months Ended September 30, 2020
	As Reported			Adjustment			As Revised
Net cash used in investing activities	$	77,317		$	(1,600	)		75,717
Net cash used in financing activities		(85,116	)		1,600			(83,516	)